{"id":"W2394733107","doi":"10.1158/1535-7163.targ-15-b29","title":"Abstract B29: A multicenter, open-label phase 1/2 study of oral CFG920, in combination with prednisone in adult patients with metastatic castration-resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Adverse effect; Prednisone; Abiraterone acetate; Internal medicine; Hyponatremia; Enzalutamide; Pharmacokinetics; Cancer; Androgen deprivation therapy; Urology; Pharmacology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001737301,0.002035971,0.002112481,0.000572641,0.0005836681,0.0009735833,0.0008728651,0.001323238,0.004881054],"category_scores_gemma":[0.0007453227,0.0007278597,0.001258728,0.0004592693,0.001118361,0.0008692005,0.0003956393,0.002827461,0.001450104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007213933,"about_ca_system_score_gemma":0.001983347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001339718,"about_ca_topic_score_gemma":0.00276904,"domain_scores_codex":[0.9994559,0.0002503186,0.00002878816,0.0001191772,0.00004759751,0.00009822842],"domain_scores_gemma":[0.9993155,0.00008375247,0.00009515438,0.00004936992,0.00004267972,0.0004136122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6118406,0.1663629,0.007262834,0.001275468,0.00129308,0.000655381,0.0004926501,0.002957718,0.1126876,0.0002374951,0.00476831,0.090166],"study_design_scores_gemma":[0.4187267,0.5635576,0.01085704,0.0000272384,0.0002874336,0.0002982442,0.00004590008,0.0006650924,0.00350882,0.00008334591,0.001907006,0.00003567461],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902463,0.001839938,0.0006003658,0.0003982787,0.000097946,0.003993016,0.001605428,0.0001206041,0.001098087],"genre_scores_gemma":[0.9874441,0.001638124,0.002047022,0.0007495292,0.0001965232,0.002940499,0.002356797,0.00003991925,0.002587493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004881054,"threshold_uncertainty_score":0.01632875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08138194030855352,"score_gpt":0.3971823865542402,"score_spread":0.3158004462456867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}